Blood and bone marrow transplantation for acute myeloid leukemia

Luis M. Villela, F Javier Bolanos Meade

Research output: Contribution to journalArticle

Abstract

Bone marrow transplantation is the treatment of choice for some patients with acute myeloid leukemia and myelodysplastic syndrome (MDS). Patients with high-risk disease, such as those with MDS, in second (or subsequent) complete remission or those with poor-risk cytogenetics will benefit the most from this approach. With current transplantation techniques, outcomes have improved over recent years. Although relapse and graft-versus-host disease still are important problems faced by these patients, novel approaches have been developed to decrease the risk of complications, with excellent results.

Original languageEnglish (US)
JournalClinical Leukemia
Volume3
Issue number2
DOIs
StatePublished - 2009

Fingerprint

Bone Marrow Transplantation
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Graft vs Host Disease
Cytogenetics
Transplantation
Recurrence
Therapeutics

Keywords

  • Donor lymphocyte infusion
  • Graft-versus-host disease
  • Myelodysplastic syndrome
  • Promyelocytic leukemia

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Blood and bone marrow transplantation for acute myeloid leukemia. / Villela, Luis M.; Bolanos Meade, F Javier.

In: Clinical Leukemia, Vol. 3, No. 2, 2009.

Research output: Contribution to journalArticle

@article{a2852b3f4cbd4fb185c83177dde366d0,
title = "Blood and bone marrow transplantation for acute myeloid leukemia",
abstract = "Bone marrow transplantation is the treatment of choice for some patients with acute myeloid leukemia and myelodysplastic syndrome (MDS). Patients with high-risk disease, such as those with MDS, in second (or subsequent) complete remission or those with poor-risk cytogenetics will benefit the most from this approach. With current transplantation techniques, outcomes have improved over recent years. Although relapse and graft-versus-host disease still are important problems faced by these patients, novel approaches have been developed to decrease the risk of complications, with excellent results.",
keywords = "Donor lymphocyte infusion, Graft-versus-host disease, Myelodysplastic syndrome, Promyelocytic leukemia",
author = "Villela, {Luis M.} and {Bolanos Meade}, {F Javier}",
year = "2009",
doi = "10.3816/CLK.2009.n.009",
language = "English (US)",
volume = "3",
journal = "Clinical Leukemia",
issn = "1931-6925",
number = "2",

}

TY - JOUR

T1 - Blood and bone marrow transplantation for acute myeloid leukemia

AU - Villela, Luis M.

AU - Bolanos Meade, F Javier

PY - 2009

Y1 - 2009

N2 - Bone marrow transplantation is the treatment of choice for some patients with acute myeloid leukemia and myelodysplastic syndrome (MDS). Patients with high-risk disease, such as those with MDS, in second (or subsequent) complete remission or those with poor-risk cytogenetics will benefit the most from this approach. With current transplantation techniques, outcomes have improved over recent years. Although relapse and graft-versus-host disease still are important problems faced by these patients, novel approaches have been developed to decrease the risk of complications, with excellent results.

AB - Bone marrow transplantation is the treatment of choice for some patients with acute myeloid leukemia and myelodysplastic syndrome (MDS). Patients with high-risk disease, such as those with MDS, in second (or subsequent) complete remission or those with poor-risk cytogenetics will benefit the most from this approach. With current transplantation techniques, outcomes have improved over recent years. Although relapse and graft-versus-host disease still are important problems faced by these patients, novel approaches have been developed to decrease the risk of complications, with excellent results.

KW - Donor lymphocyte infusion

KW - Graft-versus-host disease

KW - Myelodysplastic syndrome

KW - Promyelocytic leukemia

UR - http://www.scopus.com/inward/record.url?scp=70350333359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350333359&partnerID=8YFLogxK

U2 - 10.3816/CLK.2009.n.009

DO - 10.3816/CLK.2009.n.009

M3 - Article

AN - SCOPUS:70350333359

VL - 3

JO - Clinical Leukemia

JF - Clinical Leukemia

SN - 1931-6925

IS - 2

ER -